MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids early diagnosis and personalized management of Yao syndrome, enhancing patient care with targeted treatments and family planning insights.
Changes in the SON gene disturb RNA processing and lead to intellectual disability, developmental delay and congenital anomalies across a wide symptom range.
TRMU and SCYL1 mutations disturb mitochondrial function and protein transport, causing this infantile syndrome of liver failure, cerebellar ataxia and neuropathy.
Confirming AOS6 rests on finding the ARHGAP31 variant; because inheritance can be autosomal dominant, results also inform counseling for parents and relatives.
An involuntary shift in the sleep-wake cycle marks ASPS3, and DNA analysis can spot the hPer2 phosphorylation site mutation linked to it and to familial risk.
Understand agammaglobulinemia 8, including its autosomal dominant inheritance, infection risk, and genetic testing options.
Neurological, endocrine and pancreatic problems begin in infancy in ADMIO2, a disorder tied to PTRH2 mutations that testing can tell apart from similar syndromes.
Progressive weakness and wasting in the distal limbs mark this hereditary neuropathy. Because inheritance is dominant, each child of an affected parent has a 50% chance.